25 May 2013
Keywords: strong, ph, iii, study, data, biomarin, pku
Article | 20 August 2007
The USA's BioMarin Pharmaceutical has reported positive final results from a Phase III trial of Kuvan (sapropterin). The data, which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 2007
24 May 2013
© 2013 thepharmaletter.com